Condition
Lymphatic Reconstruction
Total Trials
3
Recruiting
2
Active
2
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
1Total
Not Applicable (1)
Trial Status
Recruiting2
Not Yet Recruiting1
Clinical Trials (3)
Showing 3 of 3 trials
NCT06887205Not ApplicableNot Yet RecruitingPrimary
Immediate Lymphatic Reconstruction After Lymphadenectomy in Melanoma Patients: a Parallel Cohort Pilot Study
NCT06650592RecruitingPrimary
Objective Assessment of Outcomes Following Immediate Lymphatic Reconstruction / LYMPHA
NCT07227467RecruitingPrimary
Prospective Assessments Following Immediate Lymphatic Reconstruction
Showing all 3 trials